FiercePharma3h
Canada locks down an initial 500K doses of GSK's bird flu vaccine
Following similar deals in countries like the United States and the U.K., Canada is bolstering its stockpile of bird flu ...
GSK to sell 500K doses of bird flu vaccines to Canada
GSK (GSK) has agreed to sell 500K doses of its avian flu vaccine to Canada to protect the country's at-risk individuals and ...
GSK announces CNMPA accepted review the new drug application for Nucala
GSK (GSK) announced that the China National Medical Products Administration, CNMPA, has accepted for review the new drug application for the ...
The Harvard Crimson16h
Biopharma Giant GSK to Expand Research and Development Footprint in Cambridge
International biotechnology company GlaxoSmithKline is moving its vaccine and infectious disease research teams to Cambridge, ...
Canada purchases 500,000 doses of GSK's vaccine for bird flu
The Government of Canada has secured an initial supply of 500,000 doses of GSK's bird flu vaccine to protect individuals most ...
Ken Griffin's Citadel Places Big Short Bet Against GSK - Here's What It Means for Investors
Ken Griffin's Citadel hedge fund places £305M short bet against GSK, with skepticism over long-term pipeline and recent stock ...
Daily4d
GSK Pharma's Q3 Profit Jumps 35% on Strong Demand for Augmentin, Respiratory Drugs
Bengaluru: India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by ...
India's GlaxoSmithKline Pharma reports higher profit on strong demand for respiratory drugs
India's GlaxoSmithKline Pharmaceuticals reported a higher adjusted third-quarter profit on Friday, led by sustained demand ...